One-stop Preclinical Services for Cancer Research
Our one-stop preclinical platform provides end-to-end solutions, from disease modeling and diagnostic development to therapeutic evaluation - all under one roof.
Read More- Home
- Solutions
- Breast Cancer
- Gastrointestinal Cancer
- Hypopharyngeal Cancer
- Laryngeal Cancer
- Oral Cancer
- Nasal and Sinus Cancer
- Nasopharyngeal Cancer
- Salivary Gland Cancer
- Lung Cancer
- Small Molecule Drug
- Therapeutic Antibody
- Therapeutic Monoclonal Antibody Development Services
- Therapeutic Polyclonal Antibody Development Services
- Therapeutic Bispecific Antibody Development Services
- Therapeutic Multispecific Antibody Development Services
- Therapeutic Antibody Fragment Development Services
- Antibody Drug Conjugate Development Services
- Antigen Development Service
- Antibody Discovery Service
- Antibody Optimization and Engineering Service
- Antibody Characterization Service
- Cell Therapy
- Gene Therapy
- Cancer Vaccine
- Peptide Therapy
- Cancer Nanomedicine
- Oncolytic Viral Therapy
- Cancer Basic Research Services
- Cell Biology Services
- Molecular Biology Services for Cancer Research
- Cancer Progression and Metabolic Analysis
- Tumorigenesis and Metastasis Analysis
- Tumor Heterogeneity Analysis
- Tumor Angiogenesis Analysis
- EMT and Tumor Metastasis Analysis
- Genetic Factors in Tumorigenesis Analysis
- Lymphangiogenesis and Lymph Node Metastasis Analysis
- Tumor Cell Heterogeneity and Plasticity Analysis
- Inflammation and Tumor Growth Analysis
- Extracellular Matrix and Tumor Metastasis Analysis
- Autophagy and Tumor Progression Analysis
- Apoptosis and Tumor Progression Analysis
- Pre-metastasis in TME Analysis
- Cellular Senescence and Tumor Progression Analysis
- Cancer Metabolism Analysis
- Analysis of Lipid Metabolism in Tumors
- Analysis of Amino Acid Metabolism in Tumors
- Analysis of Iron Metabolism in Tumors
- Analysis of Metabolic Crosstalk in the Tumors
- Analysis of Metabolic Symbiosis in Tumors
- Analysis of Redox Metabolism in Tumors
- Analysis of Reprogramming of Glycolytic Metabolism in Tumors
- Tumorigenesis and Metastasis Analysis
- Cancer Diagnostic Development Services
- Cancer Biomarker Discovery Services
- Imaging Services for Cancer Research
- Tumor Area Quantification Service
- Tissue Imaging and Analysis Service
- Tumor Microenvironment Imaging Services
- Imaging Services for Tumor Stroma
- Imaging Services for Interstitial Hypertension
- Imaging Services for Hyperpermeable Vessels
- Imaging Services for Inflammatory Responses
- Imaging Services for TME Hypoxic Ecology
- Imaging Services for Tumor Immune Microenvironment
- Imaging Services of Tumor Metabolic Microenvironment
- Imaging Services for the Acidic Tumor Microenvironment
- Imaging Services for Innervation Ecosystems in the TME
- Imaging Services of Tumor Mechanical Microenvironment
- Imaging Services for Checkpoint Molecules in TME
- Omics Services for Cancer Research
- Cancer Modeling Services
- Cancer Therapy Development Services
- Preclinical Research Services
- Efficacy Evaluation for Cancer Therapy
- DMPK/ADME for Cancer Therapy
- Safety Assessment for Cancer Drugs
- General Toxicology Evaluation for Cancer Drugs
- Genetic Toxicology Evaluation for Cancer Drugs
- Developmental and Reproductive Toxicology Evaluation for Cancer Drugs
- Immunogenicity and Immunotoxicity Evaluation for Cancer Drugs
- Local Toxicity Evaluation for Cancer Drugs
- Safety Pharmacology Evaluation for Cancer Drugs